Product

CC1083610

Aliases

BMS-986410

1 clinical trial

1 indication

Indication

Prostate Cancer

Clinical trial

A Phase 1, Multi-center, Open-label, Dose Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cc-94676 in Subjects With Metastatic Castration-resistant Prostate Cancer

Status: Recruiting, Estimated PCD: 2025-06-30